Bellevue Group AG - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 233 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2022$1,661,000
-39.2%
26,000
+2.0%
0.02%
-32.1%
Q4 2021$2,731,000
+68.8%
25,500
+26.2%
0.03%
+7.7%
Q4 2019$1,618,000
+39.4%
20,200
+27.8%
0.03%
+18.2%
Q3 2019$1,161,000
-20.6%
15,800
+1.9%
0.02%
-12.0%
Q2 2019$1,462,00015,5000.02%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders